Amount Raised
$45 Million
Round Type
Series B
Description
Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, today announced that it has raised $45 million in a Series B financing.
Who else raised in Healthcare and Health Care around the same time
Companies in the same sectors as Circle Pharma that raised within 45 days of this round, from Fundz verified event records.
- Wavegate raised $2.4M on May 1, 2020.
- Os Therapies raised an undisclosed amount on May 1, 2020.
- PAVmed raised $4.1M on May 1, 2020.
- FOLX HEALTH raised $4.3M (Seed) on May 1, 2020.
- Novabay raised an undisclosed amount on May 1, 2020.
- Suturegard Medical raised $375K (Seed) on April 30, 2020.
Who to call at Circle Pharma, and when
A new round usually means Circle Pharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Circle Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Circle Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Circle Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Circle Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCircle Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.